Literature DB >> 1359797

Novel sites for expression of an Escherichia coli heat-stable enterotoxin receptor in the developing rat.

D W Laney1, E A Mann, S C Dellon, D R Perkins, R A Giannella, M B Cohen.   

Abstract

Escherichia coli heat-stable enterotoxin (STa) mediates diarrheal disease by binding to and activating an intestinal transmembrane receptor, guanylate cyclase C (GC-C). To test the hypotheses that there was 1) increased perinatal expression of GC-C in rat intestine and 2) GC-C expression and STa binding in extraintestinal tissues of immature rat, we prepared whole cell membranes and total RNA from jejunum, ileum, colon, liver, kidney, heart, lung, brain, testis, and placenta of rats ranging in age from 12 days gestation to adult. Northern analysis demonstrated the presence of a unique 3.8-kb mRNA transcript at all ages in the jejunum, ileum, colon, and, to a lesser degree, in the testis. GC-C was also detected by Northern analysis in liver (from gestational age 18 days through 14 days postnatal) and in placenta. Steady-state mRNA encoding GC-C was not detected by Northern analysis in the other organs examined. GC-C-specific mRNA expression was greatest in the perinatal period in the jejunum, ileum, and liver. Specific binding of 125I-labeled STa was found in each of the tissue membranes in which GC-C mRNA was present; binding was not present in those tissues that had no detectable GC-C mRNA. The existence of GC-C in extraintestinal organs in the rat, and the development changes in GC-C expression support our hypothesis that GC-C, apart from its role as an STa receptor in mediating diarrheal disease, also serves as a receptor for an endogenous ligand.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359797     DOI: 10.1152/ajpgi.1992.263.5.G816

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.

Authors:  Ralph A Giannella; Elizabeth A Mann
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

Review 2.  GUCY2C ligand replacement to prevent colorectal cancer.

Authors:  Erik S Blomain; Amanda M Pattison; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

3.  Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice.

Authors:  S Schulz; M J Lopez; M Kuhn; D L Garbers
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.

Authors:  S L Carrithers; M T Barber; S Biswas; S J Parkinson; P K Park; S D Goldstein; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Analysis of the human guanylin gene and the processing and cellular localization of the peptide.

Authors:  O Hill; M Kuhn; H D Zucht; Y Cetin; H Kulaksiz; K Adermann; G Klock; G Rechkemmer; W G Forssmann; H J Mägert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

6.  The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Bonnie Taylor-Blake; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

7.  Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C.

Authors:  Hila Romi; Idan Cohen; Daniella Landau; Suliman Alkrinawi; Baruch Yerushalmi; Reli Hershkovitz; Nitza Newman-Heiman; Garry R Cutting; Rivka Ofir; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2012-04-19       Impact factor: 11.025

8.  Tyrosine phosphorylation of the human guanylyl cyclase C receptor.

Authors:  R Bhandari; R Mathew; K Vijayachandra; S Visweswariah
Journal:  J Biosci       Date:  2000-12       Impact factor: 1.826

Review 9.  Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Authors:  Hari Prasad; John Kandam Kulathu Mathew; Sandhya S Visweswariah
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

10.  Lack of guanylate cyclase C results in increased mortality in mice following liver injury.

Authors:  Elizabeth A Mann; Kumar Shanmukhappa; Mitchell B Cohen
Journal:  BMC Gastroenterol       Date:  2010-08-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.